Leishmania (L.) infantum chagasi isolated from skin lesions of patients affected by non-ulcerated cutaneous leishmaniasis lead to visceral lesion in hamsters

Carregando...
Imagem de Miniatura
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER IRELAND LTD
Citação
PARASITOLOGY INTERNATIONAL, v.93, article ID 102723, 9p, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
In Central America, Leishmania (L.) infantum chagasi infection causes visceral leishmaniasis (VL) and non -ulcerated cutaneous leishmaniasis (NUCL). The aim of the present study was to evaluate the course of an experimental infection in hamsters caused by L. (L.) infantum chagasi isolated from patients affected by NUCL compared with a strain isolated from a patient with VL. Stationary phase parasites in culture were inoculated through subcutaneous and intraperitoneal routes in hamsters. Following the post-infection times, a histopath-ological study, parasite load and cytokine determination in skin from the cutaneous inoculation site and viscera were performed. Animals subcutaneously infected with the different strains did not develop macroscopic lesions at the inoculation site, and the histopathological changes in the dermis were very slight. Regarding the histo-pathological study of the viscera, we observed the portal mononuclear inflammatory infiltrate, the presence of nodules in the hepatic parenchyma and the proliferation of macrophages in the spleen, which increased over the infection course. Overall, the parasite load in the liver and spleen and in the total IgG titres in the sera of infected hamster showed an increase with the time of infection, regardless of the route of inoculation. Regarding cellular immunity, we did not observe an increase or decrease in pro-and anti-inflammatory cytokines compared to the healthy control, except for IL-10, which was evident in the infected animals. The data showed that strains iso-lated from NUCL cause visceral lesions in the hamsters regardless of the route of inoculation, and they were similar to parasites isolated from VL humans.
Palavras-chave
Leishmania (L, ) infantum chagasi, Mesocricetus auratus, Experimental infection, Cytokines, Immunoglobulin
Referências
  1. Anam K, 1999, INFECT IMMUN, V67, P6663
  2. Andargie T.E., 2015, J CELL SCI R, V6, P1, DOI 10.4172/2157-7013.1000206
  3. ANDRADE ZILTON A., 1966, REV INST MED TROP SAO PAULO, V8, P259
  4. Antonelli LRV, 2004, CLIN EXP IMMUNOL, V136, P341, DOI 10.1111/j.1365-2249.2004.02426.x
  5. Flores GVA, 2020, PARASITE IMMUNOL, V42, DOI 10.1111/pim.12772
  6. Flores GVA, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/3487591
  7. Araujo-Santos T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04595-8
  8. Awasthi A, 2004, INDIAN J MED RES, V119, P238
  9. Bogdan C, 1998, INT J PARASITOL, V28, P121, DOI 10.1016/S0020-7519(97)00169-0
  10. Cardoso CA, 2020, MEM I OSWALDO CRUZ, V115, DOI 10.1590/0074-02760200140
  11. Carvalho LP, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00301
  12. Cecilio P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00480
  13. Coelho-Finamore JM, 2011, INT J PARASITOL, V41, P333, DOI 10.1016/j.ijpara.2010.10.004
  14. CORBETT CEP, 1992, INT J EXP PATHOL, V73, P417
  15. Crescente JAB, 2009, T ROY SOC TROP MED H, V103, P1250, DOI 10.1016/j.trstmh.2009.06.010
  16. da Silva JC, 2020, ACTA TROP, V209, DOI 10.1016/j.actatropica.2020.105539
  17. Dea-Ayuela MA, 2007, VET RES COMMUN, V31, P703, DOI 10.1007/s11259-007-0040-5
  18. DUARTE MIS, 1987, REV INST MED TROP SP, V29, P131, DOI 10.1590/S0036-46651987000300003
  19. Engwerda CR, 2000, IMMUNOL TODAY, V21, P73, DOI 10.1016/S0167-5699(99)01549-2
  20. Engwerda CR, 2004, TRENDS PARASITOL, V20, P524, DOI 10.1016/j.pt.2004.08.009
  21. GALVAOCASTRO B, 1984, CLIN EXP IMMUNOL, V56, P58
  22. Garg R, 2006, INDIAN J MED RES, V123, P439
  23. Gautam S, 2011, J INFECT DIS, V204, P1134, DOI 10.1093/infdis/jir461
  24. Gupta G, 2013, ADV APPL MICROBIOL, V82, P155, DOI 10.1016/B978-0-12-407679-2.00005-3
  25. GUTIERREZ Y, 1984, AM J PATHOL, V114, P222
  26. Hermida MDR, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00394
  27. Kaye P, 2011, NAT REV MICROBIOL, V9, P604, DOI 10.1038/nrmicro2608
  28. Kaye PM, 2004, IMMUNOL REV, V201, P239, DOI 10.1111/j.0105-2896.2004.00188.x
  29. Kedzierski L, 2014, PARASITOLOGY, V141, P1544, DOI 10.1017/S003118201400095X
  30. Kumar R, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00251
  31. Laurenti MD, 2014, VET PARASITOL, V205, P444, DOI 10.1016/j.vetpar.2014.09.002
  32. Laurenti MD, 2022, PARASITE IMMUNOL, V44, DOI 10.1111/pim.12896
  33. LAURENTI MD, 1990, INT J EXP PATHOL, V71, P791
  34. Laurenti MD, 1996, INT J EXP PATHOL, V77, P15, DOI 10.1046/j.1365-2613.1996.958096.x
  35. Lima HC, 1997, PARASITOL TODAY, V13, P80, DOI 10.1016/S0169-4758(96)40010-2
  36. Mathias R, 2001, BRAZ J MED BIOL RES, V34, P539, DOI 10.1590/S0100-879X2001000400015
  37. McCall LI, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003053
  38. MCELRATH MJ, 1988, J EXP MED, V167, P1927, DOI 10.1084/jem.167.6.1927
  39. Mears ER, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003889
  40. Melby PC, 1998, INFECT IMMUN, V66, P18, DOI 10.1128/IAI.66.1.18-27.1998
  41. Melby PC, 2001, J IMMUNOL, V166, P1912, DOI 10.4049/jimmunol.166.3.1912
  42. Meleney HE, 1925, AM J PATHOL, V1, P147
  43. Miles SA, 2005, J EXP MED, V201, P747, DOI 10.1084/jem.20041470
  44. Moreira ND, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1464-y
  45. Murray HW, 1999, J EXP MED, V189, P741, DOI 10.1084/jem.189.4.741
  46. Murray HW, 2001, INT J EXP PATHOL, V82, P249, DOI 10.1046/j.1365-2613.2001.00199.x
  47. Mutiso Joshua Muli, 2013, Scientia Parasitologica, V14, P51
  48. Loria-Cervera EN, 2014, REV INST MED TROP SP, V56, P1, DOI 10.1590/S0036-46652014000100001
  49. Nieto A, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-39
  50. Nylen S, 2007, TRENDS IMMUNOL, V28, P378, DOI 10.1016/j.it.2007.07.004
  51. OPS, 2009, MAN MAN ENF PAR PRIO
  52. Peruhype-Magalhaes V, 2005, SCAND J IMMUNOL, V62, P487, DOI 10.1111/j.1365-3083.2005.01686.x
  53. PONCE C, 1991, LANCET, V337, P67, DOI 10.1016/0140-6736(91)90734-7
  54. Ramos PK, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/6937980
  55. Requena JM, 2000, VET IMMUNOL IMMUNOP, V76, P269, DOI 10.1016/S0165-2427(00)00221-X
  56. Rica-Capela MJ, 2003, PARASITOL RES, V89, P163, DOI 10.1007/s00436-002-0738-9
  57. RIDLEY DS, 1983, J PATHOL, V141, P83, DOI 10.1002/path.1711410109
  58. RIDLEY MJ, 1986, BRIT J EXP PATHOL, V67, P209
  59. Saini S, 2020, PARASITE IMMUNOL, V42, DOI 10.1111/pim.12768
  60. Samant M, 2021, FRONT CELL INFECT MI, V11, DOI 10.3389/fcimb.2021.624009
  61. Sandoval C, 2021, J VENOM ANIM TOXINS, V27, DOI [10.1590/1678-9199-JVATITD-2020-0149, 10.1590/1678-9199-jvatitd-2020-0149]
  62. Pacheco CMS, 2021, J IMMUNOL RES, V2021, DOI 10.1155/2021/5596876
  63. Pacheco CMS, 2018, INT J EXP PATHOL, V99, P249, DOI 10.1111/iep.12295
  64. Santana CC, 2008, PARASITE IMMUNOL, V30, P515, DOI 10.1111/j.1365-3024.2008.01051.x
  65. SCHNUR L, 1973, EXP PARASITOL, V34, P432, DOI 10.1016/0014-4894(73)90103-3
  66. Silveira FT, 2009, PARASITE IMMUNOL, V31, P423, DOI 10.1111/j.1365-3024.2009.01116.x
  67. Silveira F.T., 2008, REV PARA MED, V22, P9
  68. Silveira F.T., 2021, RESOUR ANNOUNC, V10, P1, DOI [10.1128/MRA.00471-21, DOI 10.1128/MRA.00471-21]
  69. Silveira FT, 2010, T ROY SOC TROP MED H, V104, P529, DOI 10.1016/j.trstmh.2010.05.002
  70. Sosa-Ochoa W, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9070554
  71. Stanley AC, 2007, IMMUNOL CELL BIOL, V85, P138, DOI 10.1038/sj.icb7100011
  72. Tafuri Wagner Luiz, 1996, Revista do Instituto de Medicina Tropical de Sao Paulo, V38, P81, DOI 10.1590/S0036-46651996000200001
  73. Tafuri WL, 2001, VET PARASITOL, V96, P203, DOI 10.1016/S0304-4017(00)00436-2
  74. TITUS RG, 1985, PARASITE IMMUNOL, V7, P545, DOI 10.1111/j.1365-3024.1985.tb00098.x
  75. Tripathi P, 2007, FEMS IMMUNOL MED MIC, V51, P229, DOI 10.1111/j.1574-695X.2007.00311.x
  76. WILSON ME, 1987, J PARASITOL, V73, P55, DOI 10.2307/3282344